SMA Solar (S92) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
H1 2024 sales were EUR 759 million, down from EUR 779 million in H1 2023, with strong growth in Large Scale & Project Solutions offset by sharp declines in Home and C&I segments due to high inventories and postponed investments.
EBITDA fell to EUR 80.6 million from EUR 125 million, reflecting margin pressure, lower production utilization, and inflationary effects.
Free cash flow was -EUR 203 million, mainly due to increased net working capital from reduced Home and C&I sales.
Order backlog at end of June 2024 stood at EUR 1.35 billion, down from EUR 2.45 billion year-over-year, with Large Scale segment dominating.
Guidance for 2024 was revised downward due to weak demand and high inventories in key segments.
Financial highlights
Home segment revenues fell 66% year-over-year to EUR 110 million; C&I revenues dropped to EUR 113.6 million, while Large Scale sales more than doubled to EUR 536 million.
EBITDA margin was 11% (vs. 16% last year), including a EUR 19 million one-time gain from the sale of elexon stake.
Group EBIT margin was 7%, down from 14% in 2023.
Net cash decreased from EUR 283 million at 2023 year-end to EUR 66 million, mainly due to working capital build-up.
Gross cash flow dropped to EUR 53 million in H1 2024 from EUR 143 million in H1 2023.
Outlook and guidance
2024 sales guidance revised to EUR 1.55–1.7 billion, with EBITDA expected between EUR 80–130 million and EBIT of EUR 20–85 million.
Large Scale sales expected to remain strong; Home and C&I demand softer than forecast due to prolonged inventory clearance and market uncertainties.
Inventory reduction of EUR 80–100 million targeted by year-end to improve cash flow.
Net cash expected to reach EUR 100 million by year-end, driven by inventory reduction and cost controls.
Net working capital expected at 27–30% of sales by year-end.
Latest events from SMA Solar
- 2025 saw lower revenue and deeper losses, but cash flow and 2026 outlook improved despite uncertainty.S92
Q4 202526 Mar 2026 - Sharp sales and earnings drop, major restructuring, but Large Scale segment outperforms.S92
Q3 202414 Jan 2026 - 2024 sales and EBITDA declined, but restructuring aims for recovery and EBIT improvement in 2025.S92
Q4 202424 Dec 2025 - Large Scale growth offset weak Home and C&I, with cautious outlook amid tariff and market risks.S92
Q1 202525 Nov 2025 - Sales and margins fell in H1 2025, but cash flow and restructuring efforts improved outlook.S92
Q2 202523 Nov 2025 - Large Scale growth offset by HBS losses and major restructuring; outlook remains challenging.S92
Q3 202517 Nov 2025 - Revenue and earnings fell sharply in 2024, driving a renewed focus on efficiency and innovation.S92
AGM 2025 Presentation1 Jul 2025